Skip to main content
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitis
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriasis
1
1
Psoriatic Arthritis
0
1
Spondylitis, Spondylosis, Kyphosis
0
0.63
Clinical Research
0
0.56
Ankylosing Spondylitis
0
1
Arthritis
0
0.37
Hospital
0
0.37
Massachusetts
0
0.37
Biologic Therapy
0
0.7
Child
0
0.09
Grant
0
0.09
Interleukin
0
0.09
New York
0
0.09
Patient History
0
0.09
Smoking
0
0.09
Tobacco Cessation
0
0.07
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.5
Internal Medicine
0
0.6
Rheumatology
0
0.9
Orthopaedics
0
0.5
Hematology-Oncology
0
0.75
Hospital Medicine
0
0.4
Pediatrics
0
0.3
Public Health & Prevention
0
0.33
Medscape Today
0
0.29